Avacta Group (AVCT) Competitors GBX 47.75 -0.25 (-0.52%) (As of 12/20/2024 12:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines AVCT vs. SLN, OXB, PRTC, HZD, VRP, ARIX, BVXP, FARN, 4BB, and CIRShould you be buying Avacta Group stock or one of its competitors? The main competitors of Avacta Group include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), Faron Pharmaceuticals Oy (FARN), 4basebio (4BB), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry. Avacta Group vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Arix Bioscience Bioventix Faron Pharmaceuticals Oy 4basebio Circassia Group Silence Therapeutics (LON:SLN) and Avacta Group (LON:AVCT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk. Do insiders and institutionals have more ownership in SLN or AVCT? 10.2% of Avacta Group shares are held by institutional investors. 32.9% of Avacta Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in SLN or AVCT? Avacta Group received 9 more outperform votes than Silence Therapeutics when rated by MarketBeat users. However, 68.81% of users gave Silence Therapeutics an outperform vote while only 67.30% of users gave Avacta Group an outperform vote. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% Avacta GroupOutperform Votes21267.30% Underperform Votes10332.70% Which has higher valuation and earnings, SLN or AVCT? Silence Therapeutics has higher earnings, but lower revenue than Avacta Group. Avacta Group is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/AAvacta Group£22.62M7.56-£25.89M-£0.09-530.56 Is SLN or AVCT more profitable? Silence Therapeutics has a net margin of 0.00% compared to Avacta Group's net margin of -114.45%. Silence Therapeutics' return on equity of 0.00% beat Avacta Group's return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Avacta Group -114.45%-73.02%-21.80% Does the media prefer SLN or AVCT? In the previous week, Silence Therapeutics and Silence Therapeutics both had 1 articles in the media. Silence Therapeutics' average media sentiment score of 0.00 equaled Avacta Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Silence Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avacta Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummarySilence Therapeutics and Avacta Group tied by winning 5 of the 10 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVCT vs. The Competition Export to ExcelMetricAvacta GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£171.09M£165.68M£5.14B£1.89BDividend Yield3.97%3.64%5.09%5.46%P/E Ratio-530.56115.5190.131,843.16Price / Sales7.5618,531.021,117.09389,641.00Price / Cash15.0012.8743.1028.69Price / Book3.418.594.782.78Net Income-£25.89M-£20.67M£120.31M£155.66M7 Day Performance11.05%-1.05%-1.92%-2.01%1 Month Performance-2.55%174.77%13.65%21.46%1 Year Performance-57.16%134.18%28.34%29.47% Avacta Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVCTAvacta GroupN/AGBX 47.75-0.5%N/A-57.2%£171.09M£22.62M-530.56120News CoverageNegative NewsSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100News CoveragePositive NewsHigh Trading VolumeOXBOxford BiomedicaN/AGBX 423.50flatGBX 433.33+2.3%+116.5%£446.20M£97.28M-295.83891Gap DownPRTCPureTech Health2.2489 of 5 starsGBX 170+4.4%GBX 455+167.6%+2.5%£407.01M£3.33M-745.89300News CoverageHigh Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822News CoverageGap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919BVXPBioventixN/AGBX 3,480.21+0.7%N/A-23.7%£181.67M£13.60M2,135.1012FARNFaron Pharmaceuticals OyN/AN/AN/A-45.8%£175.45M£-725,000.00-524.06344BB4basebioN/AGBX 1,210+2.1%N/A+68.1%£155.00M£311,000.00-1,519.23101Positive NewsCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111News CoverageGap Down Related Companies and Tools Related Companies Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Arix Bioscience Alternatives Bioventix Alternatives Faron Pharmaceuticals Oy Alternatives 4basebio Alternatives Circassia Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:AVCT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
